Aantal gebruikers 2017-2021 voor ATC-subgroep A10B : Bloedglucoseverlagende middelen excl. insulines
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| A10BA Biguaniden | 648.470 | 651.630 | 654.150 | 659.650 | 668.770 |
| A10BB Sulfonylureumderivaten | 300.760 | 304.010 | 308.300 | 311.110 | 321.240 |
| A10BD Combinaties van bloedglucoseverlagende middelen | 10.878 | 10.951 | 11.060 | 10.710 | 10.527 |
| A10BF Alfa-glucosidaseremmers | 1.454 | 1.400 | 1.235 | 900 | 781 |
| A10BG Thiazolidinedionen | 4.704 | 3.871 | 3.250 | 2.671 | 2.390 |
| A10BH Dipeptidylpeptidase-4-remmers | 35.174 | 38.148 | 44.219 | 46.885 | 49.003 |
| A10BJ Glucagonachtig peptide-1-agonisten (glp-1-agonisten) | 12.926 | 15.895 | 26.253 | 39.515 | 55.027 |
| A10BK Natriumglucose-cotransporter-2-remmers (sglt-2-remmers) | 11.254 | 15.443 | 16.887 | 19.946 | 39.643 |
| A10BX Overige bloedglucoseverlagende middelen excl. insulines | 631 | 697 | 700 | 703 | 661 |